Loading…
CIK 0001848809 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("velan-capital-investment-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $5.5M | 5.1%Prev: 5.3% | 64,389 SH | Decreased-1,241 SH |
| ACLARIS THERAPEUTICS INC | COM | $62K | 0.1% | 32,700 SH | New |
| ALECTOR INC | COM | $163K | 0.2% | 55,000 SH | New |
| ALUMIS INC | COM | $3.8M | 3.5% | 946,683 SH | New |
| ARROWHEAD PHARMACEUTICALS IN | COM | $224K | 0.2% | 6,500 SH | New |
| AVALO THERAPEUTICS INC | COM NEW | $3.4M | 3.1%Prev: 3.7% | 263,642 SH | Decreased-60,810 SH |
| CIDARA THERAPEUTICS INC | COM NEW | $10.4M | 9.8% | 108,404 SH | New |
| CONTEXT THERAPEUTICS INC | COM | $97K | 0.1%Prev: 0.0% | 100,000 SH | Increased+40,300 SH |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | $772K | 0.7%Prev: 0.1% | 61,000 SH | Increased+35,000 SH |
| CYTOMX THERAPEUTICS INC | COM | $255K | 0.2% | 80,000 SH | New |
| DESIGN THERAPEUTICS INC | COM | $151K | 0.1% | 20,000 SH | New |
| EDESA BIOTECH INC | COM NEW | $1.7M | 1.6%Prev: 4.1% | 687,500 SH | Decreased-140,000 SH |
| ELEDON PHARMACEUTICALS INC | COM | $899K | 0.8% | 346,973 SH | New |
| ERASCA INC | COM | $142K | 0.1% | 65,000 SH | New |
| EUPRAXIA PHARMACEUTICALS INC | COM | $2.1M | 2.0%Prev: 1.4% | 352,000 SH | Decreased |
| GERON CORP | COM | $110K | 0.1% | 80,000 SH | New |
| GOSSAMER BIO INC | COM | $184K | 0.2%Prev: 0.0% | 70,000 SH | Increased |
| HERON THERAPEUTICS INC | COM | $11.0M | 10.4%Prev: 2.3% | 8,753,290 SH | Increased |
| IMMIX BIOPHARMA INC | COM | $73K | 0.1%Prev: 6.8% | 35,000 SH | Decreased-1,050,000 SH |
| IMMUNOME INC | COM | $117K | 0.1%Prev: 0.1% | 10,000 SH | Decreased |
| INSPIREMD INC | COM | $5.2M | 4.9%Prev: 0.1% | 2,143,698 SH | Increased+1,995,560 SH |
| JASPER THERAPEUTICS INC | COM NEW | $6.2M | 5.8%Prev: 0.7% | 2,668,395 SH | Increased |
| LANTHEUS HLDGS INC | COM | $3.8M | 3.5% | 73,545 SH | New |
| LARIMAR THERAPEUTICS INC | COM | $107K | 0.1%Prev: 0.1% | 33,000 SH | Increased |
| MINERALYS THERAPEUTICS INC | COM | $6.7M | 6.3%Prev: 0.2% | 175,600 SH | Increased+164,600 SH |
| NURIX THERAPEUTICS INC | COM | $148K | 0.1%Prev: 0.2% | 16,000 SH | Decreased |
| OVID THERAPEUTICS INC | COM | $208K | 0.2%Prev: 0.2% | 160,000 SH | Decreased+30,000 SH |
| PMV PHARMACEUTICALS INC | COM | $49K | 0.0% | 35,000 SH | New |
| PRAXIS PRECISION MEDICINES I | COM NEW | $7.0M | 6.6%Prev: 18.1% | 132,805 SH | Decreased+44,024 SH |
| PRECISION BIOSCIENCES INC | COM NEW | $110K | 0.1%Prev: 0.2% | 20,000 SH | Decreased-20,000 SH |
| PROQR THRAPEUTICS N V | SHS EURO | $96K | 0.1%Prev: 0.1% | 45,000 SH | Increased |
| PROTAGONIST THERAPEUTICS INC | COM | $246K | 0.2%Prev: 0.3% | 3,700 SH | Decreased |
| PROTARA THERAPEUTICS INC | COM STK | $9.3M | 8.7%Prev: 6.6% | 2,139,000 SH | Decreased-705,652 SH |
| PYXIS ONCOLOGY INC | COMMON STOCK | $122K | 0.1% | 55,000 SH | New |
| RAPT THERAPEUTICS INC | COM NEW | $2.1M | 1.9% | 79,977 SH | New |
| REPLIMUNE GROUP INC | COM | $84K | 0.1%Prev: 0.1% | 20,000 SH | Decreased |
| REZOLUTE INC | COM NEW | $7.0M | 6.6%Prev: 2.4% | 750,000 SH | Increased |
| SUTRO BIOPHARMA INC | COM | $2.7M | 2.5% | 3,120,000 SH | New |
| SYNDAX PHARMACEUTICALS INC | COM | $2.0M | 1.9%Prev: 0.1% | 130,000 SH | Increased+120,000 SH |
| TELA BIO INC | COM | $1.1M | 1.0% | 747,410 SH | New |
| TENAX THERAPEUTICS INC | COM NEW | $634K | 0.6%Prev: 5.5% | 83,333 SH | Decreased-535,352 SH |
| TERNS PHARMACEUTICALS INC | COM | $150K | 0.1% | 20,000 SH | New |
| TOURMALINE BIO INC | COM | $277K | 0.3% | 5,800 SH | New |
| TREVI THERAPEUTICS INC | COM | $1.9M | 1.8% | 205,000 SH | New |
| UNIQURE NV | SHS | $1.9M | 1.8% | 32,000 SH | New |
| VENTYX BIOSCIENCES INC | COM | $124K | 0.1% | 40,000 SH | New |
| VIRIDIAN THERAPEUTICS INC | COM | $1.9M | 1.8%Prev: 0.1% | 86,500 SH | Increased+76,500 SH |
| WAVE LIFE SCIENCES LTD | SHS | $110K | 0.1% | 15,000 SH | New |
| ZOOZ PWR LTD | SHARE | $4.3M | 4.0% | 2,000,000 SH | New |
| 13F-HR |
| 0001848809-26-000003 |
| $164.2M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001848809-25-000005 | $101.2M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001848809-26-000002 | $159.6M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000938552-25-000003 | $97.2M | View |